Medigen to hold small Phase 3 trial of its COVID-19 vaccine in Paraguay
Taipei, July 20 (CNA) Medigen Vaccine Biologics Corp. announced Tuesday that it has received permission to hold a 1,000-person Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, which was granted emergency use authorization (EUA) in Taiwan the day before.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Taiwan shuttlers Lee, Yang bag men's doubles title at German Open03/04/2024 12:24 PM
Estonian parliamentary group visits Taiwan03/04/2024 12:06 PM
U.S. dollar down in Taipei trading03/04/2024 10:58 AM
Taiwan headline news03/04/2024 10:51 AM
Taiwan shares open higher03/04/2024 09:22 AM